Cash and Cash Equivalents, at Carrying Value in USD of Orgenesis Inc. from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
Orgenesis Inc. quarterly Cash and Cash Equivalents, at Carrying Value history and change rate from Q3 2010 to Q3 2024.
  • Orgenesis Inc. Cash and Cash Equivalents, at Carrying Value for the quarter ending 30 Sep 2024 was $204K, a 271% increase year-over-year.
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

Orgenesis Inc. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2024 $204K +$149K +271% 30 Sep 2024 10-Q 13 Nov 2024
Q2 2024 $77K -$103K -57.2% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $80K -$2.59M -97% 31 Mar 2024 10-Q 20 May 2024
Q4 2023 $837K -$4.47M -84.2% 31 Dec 2023 10-Q 13 Nov 2024
Q3 2023 $55K -$2.96M -98.2% 30 Sep 2023 10-Q/A 15 Apr 2024
Q2 2023 $180K -$2.12M -92.2% 30 Jun 2023 10-Q/A 15 Apr 2024
Q1 2023 $2.67M +$1.55M +138% 31 Mar 2023 10-Q/A 15 Apr 2024
Q4 2022 $5.31M -$162K -2.96% 31 Dec 2022 10-K 15 Apr 2024
Q3 2022 $3.02M -$11.9M -79.8% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $2.3M -$26.1M -91.9% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $1.12M -$40.7M -97.3% 31 Mar 2022 10-Q 23 May 2022
Q4 2021 $5.47M -$39.5M -87.8% 31 Dec 2021 10-K 22 Mar 2023
Q3 2021 $14.9M -$73.8M -83.2% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $28.4M -$69.1M -70.8% 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 $41.8M -$65.2M -60.9% 31 Mar 2021 10-Q 06 May 2021
Q4 2020 $44.9M +$44.8M +41884% 31 Dec 2020 10-K 30 Mar 2022
Q3 2020 $88.8M +$78.1M +729% 30 Sep 2020 10-Q 05 Nov 2020
Q2 2020 $97.5M +$80.8M +485% 30 Jun 2020 10-Q 06 Aug 2020
Q1 2020 $107M +$92.3M +625% 31 Mar 2020 10-Q 08 May 2020
Q4 2019 $107K -$14.9M -99.3% 31 Dec 2019 10-K 09 Mar 2021
Q3 2019 $10.7M -$6.43M -37.5% 30 Sep 2019 10-Q 07 Nov 2019
Q2 2019 $16.7M +$11.8M +241% 30 Jun 2019 10-Q 08 Aug 2019
Q1 2019 $14.8M +$10.5M +249% 31 Mar 2019 10-Q 08 May 2019
Q4 2018 $15M +$11.5M +326% 31 Dec 2018 10-Q 07 Nov 2019
Q3 2018 $17.1M +$16.4M +2149% 31 Aug 2018 10-Q 07 Nov 2019
Q2 2018 $4.88M +$4.23M +645% 31 May 2018 10-Q 08 Aug 2019
Q1 2018 $4.23M +$353K +9.12% 28 Feb 2018 10-Q 08 May 2019
Q4 2017 $3.52M +$2.63M +295% 30 Nov 2017 10-Q 07 Nov 2019
Q3 2017 $762K +$492K +182% 31 Aug 2017 10-Q 12 Oct 2018
Q2 2017 $656K +$182K +38.4% 31 May 2017 10-Q 17 Jul 2018
Q1 2017 $3.87M +$2.94M +315% 28 Feb 2017 10-Q 16 Apr 2018
Q4 2016 $891K -$3.28M -78.6% 30 Nov 2016 10-K 13 Feb 2019
Q3 2016 $270K +$270K 31 Aug 2016 10-Q 16 Oct 2017
Q2 2016 $474K +$474K 31 May 2016 10-Q 24 Jul 2017
Q1 2016 $933K +$932K 29 Feb 2016 10-Q 19 Apr 2017
Q4 2015 $4.17M +$2.85M +217% 30 Nov 2015 10-K 28 Feb 2018
Q3 2015 $264* -$1.53M 31 Aug 2015 10-Q 14 Oct 2016
Q2 2015 $185* -$12.2K 31 May 2015 10-Q 15 Jul 2016
Q1 2015 $520* -$237K 28 Feb 2015 10-Q 14 Apr 2016
Q4 2014 $1.31M +$1.26M +2476% 30 Nov 2014 10-K 28 Feb 2017
Q3 2014 $1.53M +$1.02M +197% 31 Aug 2014 10-Q 15 Oct 2015
Q2 2014 $12.4K -$1.06M -98.8% 31 May 2014 10-Q 15 Jul 2015
Q1 2014 $237K +$187K +375% 28 Feb 2014 10-Q 14 Apr 2015
Q4 2013 $51K +$50.7K 30 Nov 2013 10-K 29 Feb 2016
Q3 2013 $516K +$203K +64.7% 31 Aug 2013 10-Q 15 Oct 2014
Q2 2013 $1.07M +$942K +740% 31 May 2013 10-Q 09 Jul 2014
Q1 2013 $50K -$304K -85.9% 28 Feb 2013 10-Q 10 Apr 2014
Q4 2012 $347* -$928 30 Nov 2012 10-K 19 Feb 2015
Q3 2012 $314K +$308K +6019% 31 Aug 2012 10-Q 15 Oct 2013
Q2 2012 $127K +$121K +2016% 31 May 2012 10-Q 15 Jul 2013
Q1 2012 $354K +$347K +4807% 29 Feb 2012 10-Q 15 Apr 2013
Q4 2011 $1.28K* -$189 30 Nov 2011 10-K 19 Feb 2014
Q3 2011 $5.13K +$642 +14.3% 31 Aug 2011 10-Q 15 Oct 2012
Q2 2011 $6.02K 31 May 2011 10-Q 25 Jun 2012
Q1 2011 $7.21K 28 Feb 2011 10-Q 20 Apr 2012
Q4 2010 $1.46K 30 Nov 2010 10-K 15 Feb 2013
Q3 2010 $4.48K 31 Aug 2010 10-Q/A 14 Nov 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.